Free Trial
NYSE:CNMD

CONMED (CNMD) Stock Price, News & Analysis

CONMED logo
$54.71 +1.33 (+2.49%)
Closing price 03:59 PM Eastern
Extended Trading
$54.76 +0.05 (+0.10%)
As of 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CONMED Stock (NYSE:CNMD)

Key Stats

Today's Range
$52.98
$54.90
50-Day Range
$47.62
$59.45
52-Week Range
$46.00
$78.19
Volume
552,572 shs
Average Volume
582,645 shs
Market Capitalization
$1.69 billion
P/E Ratio
15.50
Dividend Yield
1.46%
Price Target
$59.80
Consensus Rating
Hold

Company Overview

CONMED Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

CNMD MarketRank™: 

CONMED scored higher than 79% of companies evaluated by MarketBeat, and ranked 117th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CONMED has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CONMED has only been the subject of 2 research reports in the past 90 days.

  • Read more about CONMED's stock forecast and price target.
  • Earnings Growth

    Earnings for CONMED are expected to grow by 16.55% in the coming year, from $4.35 to $5.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CONMED is 15.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.88.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CONMED is 15.50, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.75.

  • Price to Earnings Growth Ratio

    CONMED has a PEG Ratio of 1.82. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    CONMED has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.82% of the outstanding shares of CONMED have been sold short.
  • Short Interest Ratio / Days to Cover

    CONMED has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in CONMED has recently decreased by 7.05%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CONMED pays a meaningful dividend of 1.50%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    CONMED does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of CONMED is 22.66%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CONMED will have a dividend payout ratio of 15.78% next year. This indicates that CONMED will be able to sustain or increase its dividend.

  • Read more about CONMED's dividend.
  • Percentage of Shares Shorted

    6.82% of the outstanding shares of CONMED have been sold short.
  • Short Interest Ratio / Days to Cover

    CONMED has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in CONMED has recently decreased by 7.05%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    CONMED has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for CONMED this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for CNMD on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CONMED insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.10% of the stock of CONMED is held by insiders.

  • Read more about CONMED's insider trading history.
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock News Headlines

Conmed (CNMD) Receives a Hold from Needham
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.
Conmed (CNMD) Q2 EPS Jumps 17%
See More Headlines

CNMD Stock Analysis - Frequently Asked Questions

CONMED's stock was trading at $68.44 on January 1st, 2025. Since then, CNMD stock has decreased by 20.1% and is now trading at $54.7110.

CONMED Corporation (NYSE:CNMD) announced its earnings results on Wednesday, July, 30th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. The business's revenue was up 3.1% on a year-over-year basis.
Read the conference call transcript
.

CONMED's top institutional investors include Westwood Holdings Group Inc. (4.00%), Geode Capital Management LLC (2.37%), Cooke & Bieler LP (2.26%) and Allspring Global Investments Holdings LLC (0.84%). Insiders that own company stock include Charles Farkas, Daniel S Jonas, Pat Beyer, Brian Concannon, Curt R Hartman, Martha Goldberg Aronson, Peter K Shagory, Barbara J Schwarzentraub, Johonna Marie Pelletier, John D Ferrell, Stanley W Peters III, Todd W Garner and Richard Glaze.
View institutional ownership trends
.

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CONMED investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 7/3 Dividend
6/13/2025
Ex-Dividend for 7/3 Dividend
6/13/2025
Dividend Payable
7/03/2025
Last Earnings
7/30/2025
Today
8/08/2025
Record date for 10/3 Dividend
9/15/2025
Dividend Payable
10/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
NYSE:CNMD
CIK
816956
Employees
3,900
Year Founded
N/A

Price Target and Rating

High Price Target
$68.00
Low Price Target
$55.00
Potential Upside/Downside
+9.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.53
Trailing P/E Ratio
15.50
Forward P/E Ratio
12.58
P/E Growth
1.82
Net Income
$132.42 million
Net Margins
8.31%
Pretax Margin
10.38%
Return on Equity
14.43%
Return on Assets
6.05%

Debt

Debt-to-Equity Ratio
0.88
Current Ratio
2.23
Quick Ratio
1.00

Sales & Book Value

Annual Sales
$1.31 billion
Price / Sales
1.30
Cash Flow
$6.88 per share
Price / Cash Flow
7.95
Book Value
$32.40 per share
Price / Book
1.69

Miscellaneous

Outstanding Shares
30,950,000
Free Float
29,995,000
Market Cap
$1.69 billion
Optionable
Optionable
Beta
1.17

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSE:CNMD) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners